EX-16.1 3 ea024550601ex16-1_inmed.htm LETTER FROM MARCUM LLP, DATED JUNE 12, 2025, ADDRESSED TO THE SECURITIES AND EXCHANGE COMMISSION

Exhibit 16.1

 

June 12, 2025

 

Mr. Eric A. Adams

InMed Pharmaceuticals Inc.

1445, 885 West Georgia St.

Vancouver, B.C.

Canada V6C 3E8

 

Re:InMed Pharmaceuticals Inc.

 

Dear Mr. Adams:

 

This is to confirm that the client-auditor relationship between InMed Pharmaceuticals Inc. (Commission File Number 0001728328) and Marcum llp has ceased effective June 12, 2025.

 

Very truly yours,

 

/s/ Marcum LLP

 

Marcum LLP

 

Sent Via E-Mail [email protected] [or Federal Express – Priority]

 

cc: Office of the Chief Accountant
  Securities and Exchange Commission
  Via E-Mail: [email protected]